VitaNova Life Sciences (VNOV) EBIT Margin (2017 - 2026)
VitaNova Life Sciences' (VNOV) quarterly EBIT Margin came in at 37.99% in Q3 2026, down 677.0% YoY from 6.58% in Q3 2025, and down 517.2% on a QoQ basis from 6.15% in Q2 2026.
Powered by 
Analysis
VitaNova Life Sciences (VNOV) EBIT Margin (2017 - 2026) Analysis & Trends
VitaNova Life Sciences has disclosed EBIT Margin across 7 years of filings, most recently posting 37.99% for Q3 2026.
- EBIT Margin for Q3 2026 came in at 37.99%, down 677.0% year-over-year; the trailing twelve-month figure through Jul 2026 was 2.66% (down 4861.0% YoY), and the FY2026 annual result was 0.12%, down 4527.0% from the prior year.
- EBIT Margin for Q3 2026 stood at 37.99%, down from 6.15% in the prior quarter.
- Across five years, EBIT Margin topped out at 55.41% in Q2 2025 and bottomed at 245.77% in Q1 2023.
- Average EBIT Margin over 5 years is 17.14%, with a median of 14.23% recorded in 2022.
- The widest annual swing landed in 2023, when EBIT Margin sank 27549 bps; it then soared 26856 bps in 2024.
- Year by year, EBIT Margin stood at 26.01% in 2022, then sank by 662 bps to 146.17% in 2023, then jumped by 115 bps to 21.43% in 2024, then rose by 8 bps to 23.22% in 2025, then tumbled by 264 bps to 37.99% in 2026.
- The last three EBIT Margin figures came in at 37.99% (Q3 2026), 6.15% (Q2 2026), and 6.59% (Q1 2026), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 120.96 Bn | 111.91 Bn | 6.13 Bn | 16.96% |
| 2 | UL Solutions | 12.94 Bn | 12.53 Bn | 417.00 Mn | 18.38% |
| 3 | Gartner | 11.74 Bn | 10.25 Bn | 1.19 Bn | 22.59% |
| 4 | Booz Allen Hamilton Holding | 9.28 Bn | 8.74 Bn | 1.46 Bn | 9.96% |
| 5 | Tetra Tech | 9.14 Bn | 8.91 Bn | 243.21 Mn | 12.07% |
| 6 | Genpact | 5.74 Bn | 5.22 Bn | 490.34 Mn | 14.36% |
| 7 | Grand Canyon Education | 3.97 Bn | 3.69 Bn | 204.08 Mn | 22.02% |
| 8 | Fti Consulting | 3.91 Bn | 3.74 Bn | 316.27 Mn | 8.56% |
| 9 | Korn Ferry | 3.90 Bn | 3.09 Bn | 681.29 Mn | 12.21% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.90 Mn | 30,521.00 | -37.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -6.15% |
| Jan 31, 2026 | 6.59% |
| Oct 31, 2025 | 23.22% |
| Jul 31, 2025 | -31.22% |
| Apr 30, 2025 | 55.41% |
| Jan 31, 2025 | 35.31% |
| Oct 31, 2024 | 21.43% |
| Jul 31, 2024 | -41.87% |
| Apr 30, 2024 | 42.73% |
| Jan 31, 2024 | 22.79% |
| Apr 30, 2023 | -146.17% |
| Jan 31, 2023 | -245.77% |
| Oct 31, 2022 | 26.01% |
| Jul 31, 2022 | 14.23% |
| Apr 30, 2022 | -59.57% |
| Jan 31, 2022 | 29.72% |
| Oct 31, 2021 | -66.65% |
| Jul 31, 2017 | 116.47% |